Showing 1 to 12 of 20 results
German Environmental Group Sues to Ban Pesticides Forming Harmful TFA
The German Environmental Aid is suing to ban three pesticides—Banjo, Luna Experience, and Brodal—because they form trifluoroacetic acid (TFA), a compound linked to birth defects and found in groundwater, prompting concerns about drinking water safety and the inadequacy of current pesticide regulatio...
German Environmental Group Sues to Ban Pesticides Forming Harmful TFA
The German Environmental Aid is suing to ban three pesticides—Banjo, Luna Experience, and Brodal—because they form trifluoroacetic acid (TFA), a compound linked to birth defects and found in groundwater, prompting concerns about drinking water safety and the inadequacy of current pesticide regulatio...
Progress
40% Bias Score
Bayer Raises Forecast Despite €2.2 Billion in Legal Provisions
Bayer raised its 2025 sales forecast to €46-48 billion and Ebitda to €9.7-10.2 billion, driven by pharmaceutical success, while announcing €1.7 billion in provisions for US glyphosate litigation and €530 million for PCB cases, despite settling thousands of Roundup lawsuits.
Bayer Raises Forecast Despite €2.2 Billion in Legal Provisions
Bayer raised its 2025 sales forecast to €46-48 billion and Ebitda to €9.7-10.2 billion, driven by pharmaceutical success, while announcing €1.7 billion in provisions for US glyphosate litigation and €530 million for PCB cases, despite settling thousands of Roundup lawsuits.
Progress
48% Bias Score
Bayer Extends CEO's Contract Amidst Restructuring
Bayer CEO Bill Anderson's contract is extended by three years until March 2028, following a restructuring that has eliminated 11,000 jobs and aims for €2 billion in cost savings by 2026, to address legal challenges stemming from the Monsanto acquisition.
Bayer Extends CEO's Contract Amidst Restructuring
Bayer CEO Bill Anderson's contract is extended by three years until March 2028, following a restructuring that has eliminated 11,000 jobs and aims for €2 billion in cost savings by 2026, to address legal challenges stemming from the Monsanto acquisition.
Progress
44% Bias Score
French Court Awards €325,000 for Androcur's Failure to Warn of Meningioma Risk
A French court ordered Bayer, Viatris, and Sandoz to pay €325,000 to a woman who developed meningiomas after taking Androcur for over 20 years due to their failure to adequately warn her about this risk, a ruling that could affect future legal actions.
French Court Awards €325,000 for Androcur's Failure to Warn of Meningioma Risk
A French court ordered Bayer, Viatris, and Sandoz to pay €325,000 to a woman who developed meningiomas after taking Androcur for over 20 years due to their failure to adequately warn her about this risk, a ruling that could affect future legal actions.
Progress
40% Bias Score
Bayer to Close Frankfurt Plant by 2028
Bayer announced it will close its Frankfurt plant by 2028, affecting 500 employees, due to Asian competition, overcapacity, and regulations; the Hessian state government and labor unions strongly oppose the decision.
Bayer to Close Frankfurt Plant by 2028
Bayer announced it will close its Frankfurt plant by 2028, affecting 500 employees, due to Asian competition, overcapacity, and regulations; the Hessian state government and labor unions strongly oppose the decision.
Progress
40% Bias Score
Bayer's 7% Revenue Growth in Spain Driven by Innovation and Investment
In 2024, Bayer's Spanish operations reported €822 million in revenue (a 7% increase), driven by pharmaceuticals, agriculture, and consumer health products; €145 million was invested, with €118 million dedicated to R&D and €27 million to efficiency improvements; Viralgen, a Bayer subsidiary specializ...
Bayer's 7% Revenue Growth in Spain Driven by Innovation and Investment
In 2024, Bayer's Spanish operations reported €822 million in revenue (a 7% increase), driven by pharmaceuticals, agriculture, and consumer health products; €145 million was invested, with €118 million dedicated to R&D and €27 million to efficiency improvements; Viralgen, a Bayer subsidiary specializ...
Progress
40% Bias Score
Bayer's Q2 Results Improved, but Glyphosate Litigation Adds €1.7 Billion Provision
Bayer reported better-than-expected Q2 results but added €1.7 billion to its provisions for US glyphosate and PCB litigation following an unfavorable court ruling; the Supreme Court's decision on a glyphosate case is pending, impacting future legal costs and strategy.
Bayer's Q2 Results Improved, but Glyphosate Litigation Adds €1.7 Billion Provision
Bayer reported better-than-expected Q2 results but added €1.7 billion to its provisions for US glyphosate and PCB litigation following an unfavorable court ruling; the Supreme Court's decision on a glyphosate case is pending, impacting future legal costs and strategy.
Progress
40% Bias Score
Glyphosate Cancer Study: Bayer Challenges Ramazzini Institute Findings
The Ramazzini Institute's study linked glyphosate exposure to increased cancer rates in lab rats, prompting Bayer's criticism over inconsistencies with control groups and a lack of dose-response correlation; the study's findings align with the WHO's 2015 classification of glyphosate as "probably car...
Glyphosate Cancer Study: Bayer Challenges Ramazzini Institute Findings
The Ramazzini Institute's study linked glyphosate exposure to increased cancer rates in lab rats, prompting Bayer's criticism over inconsistencies with control groups and a lack of dose-response correlation; the study's findings align with the WHO's 2015 classification of glyphosate as "probably car...
Progress
52% Bias Score
Essure Birth Control Device Faces 27,000 Complaints, FDA Scrutiny
The Essure permanent birth control device, despite FDA approval, has prompted nearly 27,000 complaints since 2002 due to reported severe side effects like pain and organ perforation, leading to sales restrictions, a black box warning, and a mandated FDA post-market trial concluding in 2023.
Essure Birth Control Device Faces 27,000 Complaints, FDA Scrutiny
The Essure permanent birth control device, despite FDA approval, has prompted nearly 27,000 complaints since 2002 due to reported severe side effects like pain and organ perforation, leading to sales restrictions, a black box warning, and a mandated FDA post-market trial concluding in 2023.
Progress
60% Bias Score
Bayer Auctions €5 Million Art Collection Amidst Work Style Changes
Bayer AG is auctioning over 800 art pieces from its collection, valued at roughly €5 million, due to a shift in work style (mobile work, open offices), thefts, and a perceived mismatch between its modern image and the German Expressionist works. The auction, managed by Philipp von Württemberg, takes...
Bayer Auctions €5 Million Art Collection Amidst Work Style Changes
Bayer AG is auctioning over 800 art pieces from its collection, valued at roughly €5 million, due to a shift in work style (mobile work, open offices), thefts, and a perceived mismatch between its modern image and the German Expressionist works. The auction, managed by Philipp von Württemberg, takes...
Progress
40% Bias Score
Bayer to Close Frankfurt Plant, Sparking Criticism and Competitiveness Concerns
Bayer announced the closure of its Frankfurt plant, employing around 500 people, by 2028 due to Asian competition, overcapacities, and regulation, prompting strong criticism from the Hessian state government and concerns about Germany's industrial competitiveness.
Bayer to Close Frankfurt Plant, Sparking Criticism and Competitiveness Concerns
Bayer announced the closure of its Frankfurt plant, employing around 500 people, by 2028 due to Asian competition, overcapacities, and regulation, prompting strong criticism from the Hessian state government and concerns about Germany's industrial competitiveness.
Progress
48% Bias Score
Bayer Appeals Glyphosate Ruling to US Supreme Court
Bayer appealed to the US Supreme Court to resolve conflicting US state rulings on glyphosate lawsuits, focusing on a 2023 Missouri case, seeking to curb the thousands of Monsanto-related claims alleging Roundup caused health problems; Bayer maintains Roundup's safety is scientifically proven and glo...
Bayer Appeals Glyphosate Ruling to US Supreme Court
Bayer appealed to the US Supreme Court to resolve conflicting US state rulings on glyphosate lawsuits, focusing on a 2023 Missouri case, seeking to curb the thousands of Monsanto-related claims alleging Roundup caused health problems; Bayer maintains Roundup's safety is scientifically proven and glo...
Progress
48% Bias Score
Showing 1 to 12 of 20 results